Merck & Co., Inc.

MRCK34.SA·São Paulo·Healthcare
Compare
103.62+4.95 (+5.02%)today
At close: Nov 4, 6:05 PM BRT · May be delayed up to 15 min · BRL

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close98.67
Open0.00
Day range100.31103.62
52-week range0.00103.62
Off day high0.00%
Off 52-week high0.00%
Volume0.00
Avg. volume (3M)5.79K
Market cap2.05T
EPS (TTM)0.6500
Forward P/E—
P/E ratio (TTM)159.42
Dividend yield1.44% (1.49)
Beta (5Y)0.12
Shares outstanding19.74B
Short interest—
Earnings dateJul 29, 2025
Analyst target—
Profit margin3.64%

Against its peers

Compare in full ›
MRCK34.SA AZN PFE GLAXO.NS JNJ.DE 0QYQ.IL
Market cap 2.05T 293.14B 175.50B 423.55B 597.86B 219.86B
P/E (TTM) 159.4 26.7 44.0 36.9 43.8 40.6
Forward P/E — 16.7 10.6 31.6 — —
Price/book 9.7 5.7 2.1 22.5 8.2 10.4
Dividend yield 1.44% 1.69% 5.59% 2.25% 1.99% 3.81%
1-year change +81.66% +12.81% +23.90% −2.83% +50.29% +40.64%
Today +5.02% +2.79% +2.63% −1.25% +2.41% +2.59%

The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.

BioXconomy·Positive

Portfolio reshuffle: Lonza buys Merck KGaA's CDMO arm

The sale gives Lonza added US manufacturing capacity and extends its run of portfolio reshaping, while Merck KGaA sharpens its life science focus. Germany’s Merck has signed an agreement to sell its contract development and manufacturing…

pharmaphorum·Positive

Merck charts course out of CDMO business with Lonza sale

Merck KGaA has moved to streamline its focus with the sale of its contract development and manufacturing organisation (CDMO) business to Lonza, a top-three player in the category, for "a mid-triple-digit million-euro amount." The deal…

MRK

From the 4Search news index, newest first.

In the news

305mentions in 30 days
305with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance